Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+10.89%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$469M
Cap. Flow %
-3.16%
Top 10 Hldgs %
34.28%
Holding
1,313
New
28
Increased
616
Reduced
266
Closed
37

Sector Composition

1 Real Estate 59.2%
2 Technology 7.88%
3 Communication Services 4.42%
4 Consumer Discretionary 3.52%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RCKT icon
1051
Rocket Pharmaceuticals
RCKT
$352M
$5K ﹤0.01%
120
RVMD icon
1052
Revolution Medicines
RVMD
$7.68B
$5K ﹤0.01%
143
VCYT icon
1053
Veracyte
VCYT
$2.55B
$5K ﹤0.01%
133
NSTG
1054
DELISTED
NanoString Technologies, Inc.
NSTG
$5K ﹤0.01%
83
DRNA
1055
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$5K ﹤0.01%
141
ALXO icon
1056
ALX Oncology
ALXO
$59.4M
$4K ﹤0.01%
79
BLUE
1057
DELISTED
bluebird bio
BLUE
$4K ﹤0.01%
10
CSTL icon
1058
Castle Biosciences
CSTL
$698M
$4K ﹤0.01%
48
GMAB icon
1059
Genmab
GMAB
$16.9B
$4K ﹤0.01%
86
GRFS icon
1060
Grifois
GRFS
$6.88B
$4K ﹤0.01%
224
HCM icon
1061
HUTCHMED
HCM
$2.77B
$4K ﹤0.01%
97
IGMS
1062
DELISTED
IGM Biosciences
IGMS
$4K ﹤0.01%
46
INO icon
1063
Inovio Pharmaceuticals
INO
$153M
$4K ﹤0.01%
34
IRWD icon
1064
Ironwood Pharmaceuticals
IRWD
$184M
$4K ﹤0.01%
301
LGND icon
1065
Ligand Pharmaceuticals
LGND
$3.23B
$4K ﹤0.01%
53
MCRB icon
1066
Seres Therapeutics
MCRB
$200M
$4K ﹤0.01%
9
MYGN icon
1067
Myriad Genetics
MYGN
$643M
$4K ﹤0.01%
141
PTGX icon
1068
Protagonist Therapeutics
PTGX
$3.5B
$4K ﹤0.01%
81
XNCR icon
1069
Xencor
XNCR
$600M
$4K ﹤0.01%
108
ZNTL icon
1070
Zentalis Pharmaceuticals
ZNTL
$118M
$4K ﹤0.01%
76
RVNC
1071
DELISTED
Revance Therapeutics, Inc.
RVNC
$4K ﹤0.01%
141
DCPH
1072
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
107
RUBY
1073
DELISTED
Rubius Therapeutics, Inc
RUBY
$4K ﹤0.01%
178
GBT
1074
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4K ﹤0.01%
116
TBIO
1075
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$4K ﹤0.01%
140